ADHERENCE TO ORAL BISPHOSPHONATE THERAPY IN PATIENTS WITH OSTEOPOROSIS IN TIANJIN, CHINA

被引：0
|
作者：
Yu, Q. [1 ]
Wu, J. [1 ]
Wang, D. [2 ]
Liu, J. [3 ]
Jin, L. [4 ]
机构：
[1] Tianjin Univ, Tianjin 300072, Peoples R China
[2] Beijing Novartis Pharma Co Ltd, Beijing, Peoples R China
[3] Tianjin Med Insurance Res Assoc, Tianjin, Peoples R China
[4] Bur Human Resource & Social Secur, Tianjin, Peoples R China
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.1145
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A226 / A226
页数：1
相关论文
共 50 条
  • [41] Improving compliance with oral bisphosphonate therapy in a pharmacist-managed osteoporosis clinic.
    Griffin, EN
    Petkov, VI
    Williams, MI
    Adler, RA
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S448 - S448
  • [42] Effect of concomitant statin therapy in bisphosphonate treated patients with osteoporosis.
    Guyer, JL
    Williams, MI
    Petkov, VI
    Adler, RA
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S400 - S400
  • [43] Should Bone Turnover Markers Be Used Routinely to Monitor Oral Bisphosphonate Osteoporosis Therapy?
    Muncie, Herbert L., Jr.
    Mohr, David J.
    Maras, Madeleine L.
    AMERICAN FAMILY PHYSICIAN, 2023, 108 (05) : 444 - 446
  • [44] The Impact of Oral Bisphosphonate Therapy on Vertebral Morphometry and Fractures in Patients with Duchenne Muscular Dystrophy and Glucocorticoid-Induced Osteoporosis
    Nasomyont, Nat
    Tian, Cuixia
    Hornung, Lindsey
    Khoury, Jane
    Hochwalt, Paul
    Tilden, Joshua Cole
    Rybalsky, Irina
    Wong, Brenda
    Rutter, Meilan
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 : 79 - 80
  • [45] An oral complication of bisphosphonate therapy
    Khanna, Sagar
    Prendes, Brandon
    BMJ-BRITISH MEDICAL JOURNAL, 2024, 386
  • [46] Predicting Adherence and Persistence with Oral Bisphosphonate Therapy in an Integrated Health Care Delivery System
    Hui, Rita L.
    Adams, Annette L.
    Niu, Fang
    Ettinger, Bruce
    Yi, David K.
    Chandra, Malini
    Lo, Joan C.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (04): : 503 - 512
  • [47] How common is loss of bone mineral density in elderly clinical practice patients receiving oral bisphosphonate therapy for osteoporosis?
    Lewiecki, E
    Rudolph, LA
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S367 - S367
  • [48] The effect of oral bisphosphonate therapy on vertebral morphometry and fractures in patients with Duchenne muscular dystrophy and glucocorticoid-induced osteoporosis
    Nasomyont, Nat
    Tian, Cuixia
    Hornung, Lindsey
    Khoury, Jane
    Hochwalt, Paul M.
    Tilden, Joshua Cole
    Wong, Brenda L.
    Rutter, Meilan M.
    MUSCLE & NERVE, 2021, 64 (06) : 710 - 716
  • [49] Adherence with bisphosphonate therapy and change in bone mineral density among women with osteoporosis or osteopenia in clinical practice
    D. Weycker
    L. Lamerato
    S. Schooley
    D. Macarios
    T. Siu Woodworth
    N. Yurgin
    G. Oster
    Osteoporosis International, 2013, 24 : 1483 - 1489
  • [50] Osteoporosis in patients under oral anticoagulant therapy
    Wellhöfer, B
    Kemkes-Matthes, W
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (48) : 2790 - 2790
12345